AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06646510 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sensory electrical stimulation
Description: The stimulated muscles included the flexor carpi radialis (FCR), extensor carpi radialis (ECR), and flexor carpi ulnaris (FCU). Rectangular surface electrodes (Ag/AgCl; 50mm _ 50mm size) were attached on the motor point of each muscle, i.e., at four fingerbreadths from biceps tendon of FCR, at two fingerbreadths distal from lateral epicondyle for the ECR, at two fingerbreadths volar to ulna at the junction of the upper and middle thirds of the forearm for FCU.14 Portable stimulators will use with the following stimulation settings: constant current (0.2 mA step), 100 Hz stimulation frequency, biphasic pulse, and 300 _s pulsewidth.
Study NCT04912388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbal stabilization excercises
Description: The stabilization group will perform lumbal stabilization exercises in lying, sitting, standing and on a swisball 3 times a week during 6 weeks.
Study NCT04912388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional exercises
Description: The general exercise group will perform conventional exercises 3 times a week during 6 weeks.
Study NCT06649279 — intervention group
Intervention type: DEVICE
Intervention: Oxygen reserve index
Description: Measuring oxygen reserve index during preoxygenation and under general anesthesia
Study NCT06648902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: meldonium
Description: 500 mg (Arm A) or 1,000 mg (Arms B and C) orally daily, weeks 1-6
Study NCT06648525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab, IV
Study NCT06648525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan liposomes
Description: Irinotecan liposomes, IV
Study NCT06648525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib, po
Study NCT06648525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU)
Description: 5-Fluorouracil (5-FU), IV
Study NCT06648525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium Folinate
Description: Calcium folinate, IV
Study NCT05141643 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET Scan
Description: Participants will receive a minimum of 4 mCi (148 MBq) and up to a maximum of 10 mCi (370 MBq) of \[18F\]-FAC intravenously. Injection is performed in conjunction with a dynamic PET acquisition over a site of the disease (pre-selected based on the findings from a previous CT or MRI and FDG PET/CT study done for clinical purpose such as staging). Patients will be offered a second \[18F\]-FAC PET scan procedure during their SOC treatment. This second scan will be optional.
Study NCT05236231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan 10 mg
Description: Macitentan 10mg tablet will be administered orally as per assigned treatment sequence.
Study NCT05236231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Description: Tadalafil 20mg tablet will be administered orally as per assigned treatment sequence.
Study NCT05236231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan 10 mg/Tadalafil 20mg FDC
Description: FDC of Macitentan 10 mg/Tadalafil 20 mg will be administered orally as single dose tablets.
Study NCT06559852 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: Participants will engage in a 12-week virtual yoga course to assess impact on endometriosis-related pain
Study NCT05625191 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Acoustic voice analysis
Description: Acoustic recordings will involve the five repetitions of three vowels (/ɑ, i, u/) and a standard reading passage (Rainbow Passage) in different voice conditions. Control participants will produce voice in breathy, typical, and pressed conditions. Patient participants will produce voice in typical production and in a resonant voice production. High-speed videoendoscopy and simultaneous acoustic recording will occur on one repetition of a sustained /i/ in each requested condition. Data will be collected using a head-mounted microphone.
Study NCT05625191 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: High-speed videoendoscopy
Description: High-speed videoendoscopy will occur on one repetition of a sustained /i/ in each requested condition. Exams will be recorded using the Phantom V311 high-speed camera (Vision Research, Wayne, NJ) connected to a Storz 70° rigid laryngoscope using a 400 Watt Xenon light source (Titan 400E).
Study NCT05605639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: The experimental intervention will consist of ultrasound-guided anesthetic blockade of the phrenic nerve at the laterocervical supraclavicular level with 1 ml of lidocaine without vasoconstrictor 2% to infiltrate the skin and 3ml of bupivacaine without vasoconstrictor 0.25% for neural blockade, making the local anesthetic surround the nerve between the anterior scalene muscle and the sternocleidomastoid muscle.
Study NCT05605639 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (physiological saline serum infiltration)
Description: The placebo intervention will be similar in relation to 2% lidocaine without vasoconstrictor for the skin, but an ultrasound-guided puncture will be performed at the level of the subcutaneous cellular tissue by injecting 3 ml of physiological saline.
Study NCT04242992 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CETA
Description: CETA is a modular, multi-problem, flexible psychotherapy approach that trains a lay provider in nine evidence-based CBT elements so providers can treat a variety of common problems, including violence, substance use, depression, anxiety, risky behaviors (sexual, non-adherence), and other trauma-related symptoms. Patients randomized to CETA will meet weekly with a lay provider or community health worker member of the study staff for about an hour once each week, approximately 6-12 times depending on presentation and symptom level. This treatment arm will include SMS reminders of their HIV care appointments, similar to the active control group.
Study NCT04242992 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Short Message Service (SMS) text reminders
Description: Short Message Service (SMS) text reminders for upcoming appointments will be sent monthly.
Study NCT04242992 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short Message Service (SMS) text reminders
Description: Short Message Service (SMS) text reminders for upcoming appointments will be sent monthly.
Study NCT04658706 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A supervised exercise program
Description: is a 12-week exercise program supervised by specially trained instructors combining moderate to high intensity aerobic and strength exercises (three 1 hour sessions a week).
Study NCT04658706 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: exercise prescription
Description: they will receive a prescription concerning healthy lifestyles and a personalized exercise plan
Study NCT05074446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: stereotype threat manipulation
Description: Stereotype threat is the thought that a person will be negatively evaluated and judged regarding a negative stereotype that belongs to the group to which he/she belongs.~Stereotype threat manipulation will be performed on the intensivist and non-intensivist participants in the experimental group just before they are taken into the testing room. For manipulation, the following sentences will be said to the participants in the experimental group: We aim to compare the cardiopulmonary resuscitation performance between intensive care units and other branches. The other participants (Control Group) will not be given any prior information.
Study NCT05574803 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active-tDCS
Description: Active-tDCS (1 mA) over the supplementary motor area (SMA) for 5 sessions (20 minutes per session, weekly), along with behavioural therapy of speaking tasks (i.e., story narration and conversation) using the minimum prolongation technique based on the Camperdown Program.
Study NCT05574803 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham-tDCS
Description: Sham-tDCS (1 mA) over the supplementary motor area (SMA) for 5 sessions (one minutes per session, weekly), along with behavioural therapy of speaking tasks (i.e., story narration and conversation) using the minimum prolongation technique based on the Camperdown Program. Participants will receive initial stimulation for one minute, eliciting a tingling sensation on the scalp then it will be discontinued.
Study NCT05190822 — intervention group
Intervention type: OTHER
Intervention: College student
Description: Our research will be conducted by face-to-face interviews within the scope of questionnaires prepared by us for students studying in departments other than Physiotherapy and Rehabilitation at Acibadem Mehmet Ali Aydinlar University.
Study NCT04948034 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Ablative Radiotherapy (SABR)
Description: We plan to irradiate as many metastatic lesions as possible, in the precondition that normal tissues can tolerate.~Target dose will be adjusted depending on site of the lesion and organs at risk (BED > 100Gy).~Treatment schedule is once per day and five days per week. Sequence of irradiation for multiple metastases is at the discretion of the investigators based on their experience.
Study NCT04948034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib
Description: Starts within two weeks upon SABR completion: 5mg, d1-14, qd; Continued until disease progression, unacceptable toxicity or patient withdrawal.
Study NCT04948034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Starts within one week upon SABR completion: 200mg, d1, q3w; the dosing will continue for up to two years until disease progression, unacceptable toxicity or patient withdrawal.
Study NCT05351541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin therapy with Zolpidem and Modafinil
Description: 1-30 mg (oral administration), Modafinil (oral administration), and Zolpidem (oral administration)
Study NCT05351541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin therapy with Zolpidem
Description: 1-30 mg (oral administration), Zolpidem (oral administration), and placebo (oral administration)
Study NCT05351541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin therapy with Modafinil
Description: 1-30 mg (oral administration), Modafinil (oral administration), and placebo (oral administration)
Study NCT05351541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin therapy with Placebo
Description: 1-30 mg (oral administration), and placebo (oral administration)
Study NCT05766345 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG-Vaccine SSI [Statens Serum Institut]) Danish strain 1331
Description: Nothing to add
Study NCT05766345 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nothing to add
Study NCT04272827 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Liposuction
Description: Liposuction treatment will be performed according to the study protocol using the wet technique depending on the amount of fat to be removed, if necessary in several sessions.
Study NCT04272827 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Liposuction
Description: Liposuction treatment will be performed according to the study protocol using the wet technique depending on the amount of fat to be removed, if necessary in several sessions.
Study NCT05561946 — intervention group
Intervention type: DEVICE
Intervention: Owlet OSS 3.0
Description: The Owlet OSS 3.0 is worn continuously for a minimum of 48 hours and the skin where the device is worn is monitored for any skin injury/irritation
Study NCT04981093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone Injection
Description: Intravenous injection after induction of anesthesia~Injection 0.15mg/kg dexamethasone (2ml)
Study NCT04981093 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: 2ml of normal saline was injected intravenously after induction of anesthesia
Study NCT04954716 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Deep Neck Flexor Massage
Description: Deep friction massage is a specific connective tissue massage that was given across the affected fibers.The therapist's fingers and patient's skin must move as one, otherwise moving subcutaneous fascia against muscle or ligament could lead to blister formation or subcutaneous bruising.The friction massage must have sufficient sweep and be deep enough.
Study NCT04954716 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Post-Isometric Relaxation Technique
Description: The PIR technique is performed as follows.The hypertonic muscle is taken to a length just short of pain, or to the point where resistance to movement is first noted.A submaximal (10-20%) contraction of the hypertonic muscle is performed away from the barrier for between 5 and 10 seconds and the therapist applies resistance in the opposite direction . The patient should inhale during this effort.After the isometric contraction the patient is asked to relax and exhale while doing so.Following this a gentle stretch is applied to take up the slack till the new barrier.Starting from this new barrier, the procedure is repeated two or three times.
Study NCT06479447 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PORTAL-PTSD
Description: Patients will be eligible if they are 18+ years, have had a primary care visit in the last 2 years, and have not been screened for PTSD in the last year. The validated PC-PTSD-5 (Primary Care Post Traumatic Stress Disorder-5) screener will be used. Clinics will implement visit-based and population health screening for patients enrolled in the patient portal who have not been screened for PTSD in the last year and have had a clinic appointment in the last 2 years. The PCBH care manager or patient navigator will follow-up with patients every 2 weeks to ensure they have been connected to care and re-measure their PTSD symptoms. The follow-up calls will continue until symptom remission, after which follow-ups will occur quarterly for 6 months. Primary care clinicians will receive training on trauma-informed care and PTSD management, and will be surveyed at baseline, immediately after training, and 6 months-post intervention to evaluate changes in their knowledge of trauma-informed care.
Study NCT06274450 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: skin care product
Description: Subjects are uniformly using skin care products provided by the sponsor during the test. Skin care product include: WINONA sensitiveness relieving moisturizing cleansing foam, WINONA sensitiveness relieving moisturizing lotion, WINONA anti-sensitive tolerance-extreme moisturizing cream
Study NCT06274450 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: skin care product
Description: Subjects are uniformly using skin care products provided by the sponsor during the test. Skin care product include: WINONA sensitiveness relieving moisturizing cleansing foam, WINONA sensitiveness relieving moisturizing lotion, WINONA anti-sensitive tolerance-extreme moisturizing cream
Study NCT06274450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Drinks with active ingredients Rosa Roxburghii and Pomegranate
Description: Take drinks with active ingredients such as Rosa Roxburghii and Pomegranate. Drink every morning on an empty stomach, 20ml/2 sachets/day.
Study NCT04529512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DEXTENZA®
Description: DEXTENZA® is a corticosteroid implant indicated for the treatment of ocular pain following ophthalmic surgery. DEXTENZA® is inserted into the lower lacrimal punctum into the canaliculus by the physician following ophthalmic surgery. A single DEXTENZA® releases a 0.4 mg dose of dexamethasone for up to 30 days following insertion. DEXTENZA® is preservative free, resorbable and does not require removal. Saline irrigation or manual expression can be performed to remove the insert, if necessary.
Study NCT05569928 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Administration of deuterated compounds for kinetic study
Description: Participants will be submitted to a standardized oral-fat load and kinetic study will be performed
Study NCT04687020 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Viltolarsen
Description: Received during weekly intravenous infusions
Study NCT06408064 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Music therapy is a non-pharmacological therapeutic intervention that will be implemented through two modalities: live and pre-recorded instrumental lullabies music.The volume control will be conducted within the groups through the use of a decibel regulator, with a maximum volume of 70 dB. During the intervention and for a period of 30 minutes following its conclusion, singing will be prohibited by the music therapist or the parents. Both live and pre-recorded music will be instrumental in nature, lacking any lyrics.
Study NCT04801472 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Optimisation of dental implant sites protection from irradiation
Description: Optimal treatment plan validation after two dosimetric computer-tomography scans (with or without radiological guide) and visualisation of virtual dental implants on scanner images.~Evaluation of toxicity, quality of life and dental implant survival rate
Study NCT04147624 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Souvenaid
Description: Souvenaid is an oral beverage that contains a vitamin mixture (Vitamin A, B1, B2, B3, B5, D) plus three main active ingredients: omega-3 fatty acids, uridine monophosphate, and choline.
Study NCT04147624 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The Placebo used in this study is an oral beverage vitamin mixture containing Vitamins A, B1, B2, B3 and B5.
Study NCT05998434 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Improving Low Back Pain Through Motor Control Training
Description: In the digital healthcare group, participants utilized app-based online motor control training. In contrast, participants in the traditional treatment group underwent motor control training under the guidance of healthcare professionals at the hospital.
Study NCT05998434 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Improving Low Back Pain Through Motor Control Training
Description: In the digital healthcare group, participants utilized app-based online motor control training. In contrast, participants in the traditional treatment group underwent motor control training under the guidance of healthcare professionals at the hospital.
Study NCT05808062 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Root canal obturation
Description: Root canal dryness
Study NCT05645900 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Quadrivalent influenza virus subunit vaccine
Description: This vaccine（0.5ml） is produced by Ab\&b Biotechnology Co., Ltd.JS。Subjects will receive two doses of quadrivalent influenza virus subunit vaccine administered 28 days apart by intramuscular injection
Study NCT05645900 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Quadrivalent influenza virus subunit vaccine
Description: This vaccine（0.25ml） is produced by Ab\&b Biotechnology Co., Ltd.JS。Subjects will receive two doses of quadrivalent influenza virus subunit vaccine administered 28 days apart by intramuscular injection
Study NCT05645900 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Quadrivalent split influenza virus vaccine
Description: This vaccine（0.25ml） is produced by HUALAN BIO。Subjects will receive two doses of quadrivalent split influenza virus vaccine administered 28 days apart by intramuscular injection
Study NCT04977362 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery
Description: Enhanced recovery after surgery is a multimodal, transdisciplinary care approach for patients undergoing surgical procedures. It is implemented in various surgical specialties, among others in cardiac surgery. The care approach aims at promotion of recovery of the patients throughout their perioperative process, reduction of complications, and early return to normal activities.
Study NCT04977362 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: treatment as usual according to standard care in heart valve surgery
Study NCT05124002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Adenovirus Type 5
Description: H101 will be intratumorally injected 3 days before HAIC. Dosage of H101: 1 vial (5.0 × 10\^11 vp) if the maximum diameters of lesion ≤ 5 cm, 2 vials (1.0 × 10\^12 vp) if the maximum diameters of lesion ≤ 10 cm, 3 vials (1.5 × 10\^12 vp) if the maximum diameters of lesion is > 10 cm.
Study NCT05124002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HAIC of FOLFOX
Description: Oxaliplatin 50 mg + 5-FU 1.5 g + leucovorin calcium. The infusion will be continued for 2-3 days according to patients' tolerance and tumor conditions. The standard treatment for HAIC consists of 4-6 cycles, with the second cycle being 3 weeks after the end of the first HAIC cycle and the subsequent cycles being 4 weeks after the end of the previous HAIC.
Study NCT00766285 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Trivalent inactivated influenza vaccine
Description: Standard trivalent influenza vaccine consisting of 15 mcg per antigen (45 mcg total) by intramuscular deltoid injection.
Study NCT00766285 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trivalent Baculovirus-expressed Influenza HA vaccine
Description: Influenza virus hemagglutinin proteins expressed in insect (SF+) cells under serum free conditions by recombinant baculovirus.